Postmenopausal breast cancer: is the short-term pain worth the long-term gain?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 1996
has subject area
- 11 Medical and Health Sciences (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Female (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Multicenter Studies as Topic (MeSH)
- Postmenopause (MeSH)
- Quality-Adjusted Life Years (MeSH)
- Receptors, Estrogen (MeSH)
- Tamoxifen (MeSH)
published in
- The Lancet Journal